LGBTQ+ youth are struggling in the wake of executive orders restricting gender affirming care, medical experts say. They’re experiencing heightened depression, anxiety and suicidal ideation.
A big story in markets so far this year is small-cap health care stocks, though you may not hear that in the media too often.
Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...